← Back to search

Schrodinger Inc

SDGR · NASDAQ

Pharmaceutical Preparation Manufacturing

Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger's multidisciplinary drug discovery team also leverages its software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.

ESG Scores

Overall ESG
2.5
Environmental
6.7
Social
3.4
Governance
5.7

Gender Diversity

Female Directors0.22219999999999998%
Female Executives0.41379310344827586%
CEO GenderMale

Market Data

Price$12.80+0.46 (+3.73%)
Market Cap$911M
P/E Ratio
EPS$—
52W High$27.63
52W Low$10.95
Beta1.61